A Study of LY2624803 in Participants With Transient Insomnia

NCT01779830 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Transient Insomnia

Interventions

DRUG: LY2624803 - Capsules
DRUG: Zolpidem - Tablets
DRUG: Placebo - Capsules
DRUG: Placebo - Tablets

Sponsor

Eli Lilly and Company